{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:56:48Z","timestamp":1792706208049,"version":"4.5.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMCACA"],"published-print":{"date-parts":[[2002,3,1]]},"DOI":"10.2174\/1568011023354146","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T19:24:16Z","timestamp":1111692256000},"page":"267-310","source":"Crossref","is-referenced-by-count":103,"title":["The Prodrugs of 5-Fluorouracil"],"prefix":"10.2174","volume":"2","author":[{"given":"M.","family":"Malet-Martino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Jolimaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Medicinal Chemistry-Anti-Cancer Agents"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/92036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T05:07:07Z","timestamp":1448255227000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1568-0118&volume=2&issue=2&spage=267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568011023354146","relation":{},"ISSN":["1568-0118"],"issn-type":[{"value":"1568-0118","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3,1]]}}}